Navigation Links
Asthma and eczema sufferers have a lower risk of developing a cancer
Date:7/20/2010

This press release is available in French.

Men who had a history of asthma or eczema generally had a lower risk of developing cancer, according to a study carried out by researchers at INRSInstitut Armand-Frappier, the Research Centre of the Centre hospitalier de l'Universit de Montral, and McGill University. The findings, published in the Annals of Allergy, Asthma & Immunology, show that male eczema sufferers had a lower risk of lung cancer while those with a history of asthma had a similar effect in relation to stomach cancer.

"Asthma and eczema are allergies brought about by a hyper-reactive immune system a state which might have enabled abnormal cells to have been eliminated more efficiently, thereby reducing the risk of cancer," explained Professor Marie-Claude Rousseau of the INRSInstitut Armand-Frappier, one of the co-authors of the research.

The researchers analyzed information that was collected in a study on exposures in the workplace and the risk of developing cancer, undertaken between August 1979 and March 1986. It involved 3,300 men, between 35 and 70 years of age, who had been diagnosed with cancer in one of Montreal's 18 hospitals, and a control group of 512 people from the general population who did not have cancer. The researchers used the data from this study to determine if there was a link between allergies such as asthma and eczema and the incidence of eight most common types of cancer.

These findings contribute important knowledge to population health and provide new research leads. Although the study did not allow to identify which specific factors related to asthma and eczema were responsible for reducing the risk of cancer, it offers new angles for research into the molecular and immunological mechanisms that are involved in immunostimulation, a potentially promising strategy for cancer prevention.


'/>"/>

Contact: William Raillant-Clark
william.raillant-clark@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert

Related biology news :

1. RSV may hide in the lungs, lead to asthma, UT Southwestern researchers report
2. Pregnant women with asthma can be more confident about some medicines
3. New asthma research opposes current drug treatment, says UH prof
4. Fast-food diet cancels out benefits of breastfeeding in preventing asthma
5. Eosinophils as markers for asthma
6. Indoor air pollution increases asthma symptoms
7. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
8. Airborne asthma allergens
9. Vitamin D levels linked to asthma severity
10. Athletes with asthma need more help from their team trainers
11. Alzheimers, asthma, cancer, malaria and TB focus of new Singapore grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... 2017  The latest mobile market research from Acuity ... dramatically. The quarterly average price of a biometric smartphone ... Q4 2016.  There are now 120 sub-$150 models on ... from just 28 a year ago at an average ... Maxine Most , Acuity Market Intelligence Principal, "Biometric Smartphones ...
(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
(Date:1/12/2017)...  New research undertaken by Fit Small Business ... participants were simply asked which office technology had they not ... standard issue.  Insights on what will be key ... futurists and industry leaders including Penelope Trunk , ... Some of these findings included; ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 16, 2017   Biostage, Inc. (Nasdaq: ... company developing bioengineered organ implants to treat cancers and ... announced today the closing on February 15, 2017 of ... common stock and warrants to purchase 20,000,000 shares of ... The offering was priced at $0.40 per share of ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
(Date:2/16/2017)...  Windtree Therapeutics, Inc. (Nasdaq: WINT ... KL4 surfactant therapies for respiratory diseases, announced today ... that aerosolized KL4 surfactant reduced lung inflammation and ... model. The Company believes that these preclinical data ... supports the role of KL4 surfactant as a ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... industry leading Biochemistry Services specifically targeting the rapidly growing needs of the ... the biochemical and biosimilar characterization , product-related impurity characterization, aggregation ...
Breaking Biology Technology: